Bedaquiline containing regimens for the treatment of multi- and extensively drug-resistant tuberculosis at the programmatic level in Belarus. Prospective cohort study.

A. Skrahina (Minsk, Belarus), H. Hurevich (Minsk, Belarus), S. Setkina (Minsk, Belarus), V. Grankov (Minsk, Belarus), V. Solodovnikova (Minsk, Belarus), D. Viatushka (Minsk, Belarus), V. Kralko (Minsk, Belarus), D. Klimuk (Minsk, Belarus), M. Dara (Copenhagen, Denmark)

Source: International Congress 2019 – Drug-resistant tuberculosis
Session: Drug-resistant tuberculosis
Session type: Oral Presentation
Number: 2136
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Skrahina (Minsk, Belarus), H. Hurevich (Minsk, Belarus), S. Setkina (Minsk, Belarus), V. Grankov (Minsk, Belarus), V. Solodovnikova (Minsk, Belarus), D. Viatushka (Minsk, Belarus), V. Kralko (Minsk, Belarus), D. Klimuk (Minsk, Belarus), M. Dara (Copenhagen, Denmark). Bedaquiline containing regimens for the treatment of multi- and extensively drug-resistant tuberculosis at the programmatic level in Belarus. Prospective cohort study.. 2136

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: